Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization

Ophthalmic Research

Volumn 33, Issue 6, 2001, Pages 353-362

  Ma, David Hui Kang ^a,b   Chen, Jan Kan ^c   Kim, Wan Soo ^a,d,e   Hao, Yan Xia ^a   Wu, Hui Chuan ^b   Tsai, Ray Jui Fang ^b   Hwang, David G ^a   Zhang, Fen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d Maryknoll Hospital   (South Korea)

^e Pusan National University   (South Korea)

Author keywords

Corneal neovascularization; Inflammation; Matrix metalloproteinase; Rat; Tissue inhibitor of metalloproteinase

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B; SILVER NITRATE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAUTERIZATION; CELL INFILTRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA NEOVASCULARIZATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; VASCULAR ENDOTHELIUM; WOUND HEALING; ZYMOGRAPHY;

ANIMALS; CORNEAL NEOVASCULARIZATION; FEMALE; IMMUNOENZYME TECHNIQUES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SILVER NITRATE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0035676921     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055693     Document Type: Article

References (35)

1. Hypotheses about the pathogenesis of corneal vascularization
2. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization
3. Binding of basic fibroblast growth factor to normal and neovascularized rabbit cornea
4. Plasminogen activators and matrix metalloproteinases in angiogenesis
5. Metalloproteases and urokinase in angiogenesis and tumor progression
6. The matrix metalloproteinase family
7. Matrix metalloproteinase-9 (92 kD gelatinase/type IV collagenase) from U937 monoblastoid cells: Correlation with cellular invasion
8. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
9. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing
10. Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas
11. Immunolocalization and gene expression of matrilysin during corneal healing
12. Mechanism of basement membrane dissolution preceding corneal ulceration
13. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury
14. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodeling cornea
15. Early TIMP gene expression after corneal infection with Pseudomonas aeruginosa
16. Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis
17. Keratoconus corneas: Increased gelatinolytic activity appears after modification of inhibitors
18. Increased gelatinolytic activity in keratoconus keratocyte cultures
19. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells: Effects of tumour necrosis factor alpha, interleu-kin 1 and phorbol ester
20. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells
21. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors
22. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
23. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration
24. Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases
25. Morphologic observations on experimental corneal vascularization in the rat
26. A model of angiogenesis in the mouse cornea
27. Corneal neovascularization in rats as a model for photothrombotic therapy using bacteriochlorin a and an argon laser
28. Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization
29. Recombinant PEX, a non-catalytic fragment of matrix metalloproteinase-2 (MMP-2), inhibits corneal neovascularization
30. Cellular events associated with inflammatory angiogenesis in the mouse cornea
31. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms
32. Platelet derived collagenase inhibitor: Characterization and subcellular localization
33. Up-regulation of collagenase (MMP-1 and -13) and gela-tinases (MMP-2 and -9) in vascularized rabbit corneal epithelium
34. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metallopro-teinase 4
35. Microscopic localization of active proteases by in situ zymography: Detection of matrix metalloproteinase activity in vascular tissue